Cardiogenic Shock Complicating Myocardial
Infarction: An Updated Review

Adel Shabana; Mohamed Moustafa; Ayman El-Menyar; Hassan Al-Thani

British Journal of Medicine and Medical Research

British Journal of Medicine and Medical Research, ISSN: 2231-0614,Vol.: 3, Issue.: 3 (July-September)

Review Article

Cardiogenic Shock Complicating Myocardial Infarction: An Updated Review

Adel Shabana^1,2, Mohamed Moustafa¹, Ayman El-Menyar^2,3,4*and Hassan Al-Thani⁵

¹Department of cardiology, Hamad Medical Corporation, Qatar.
²Department of clinical medicine, Weill Cornell Medical School, Qatar.
³Clinical research, Trauma section, Hamad General Hospital, Qatar.
⁴Cardiology unit, Ahmed Maher Teaching Hospital, Cairo, Egypt.
⁵Vascular surgery, Hamad general hospital, Doha, Qatar.

Article Information

Editor(s):

(1) Marianna Mazza, Department of Neurosciences, Catholic University of Sacred Heart, Rome, Italy.

Reviewers:

(1) J. P. S. Henriques, University of Amsterdam, Netherlands.

(2) Anonymous.

(3) Werdan Karl, University Clinics Halle (Saale), Germany.

Complete Peer review History: http://www.sciencedomain.org/review-history/995

Abstracts

The current review aimed to highlight the update management in patients with ischemic Cardiogenic shock (CS) and its impact on mortality. We reviewed the literature using search engine as MIDLINE, SCOPUS, and EMBASE from January 1982 to October 2012. We used key words: “Cardiogenic Shock”. This traditional narrative review did not expand to explore the mechanical complications or other causes of CS. There were 7193 articles assessed by 3 reviewers. We excluded 4173 irrelevant articles, 1660 non-English articles and 93 case-reports. The current review evaluated 888 articles (880 studies and 8 meta-analyses) that were tackling ischemic CS from different points of view before and after the era of SHOCK trial. Ischemic CS remains the most serious complication of acute MI, being associated with high mortality rate both in the acute and long-term setting, despite the advances in its pathophysiology and management. Further randomized trials and guidelines are needed to save resources and lives in patients sustained ischemic CS.

Keywords :

Myocardial infarction; cardiogenic; shock; management.

Full Article - PDF Page 622-653 Article Metrics

DOI : 10.9734/BJMMR/2013/2464

Review History Comments

Search this site

Advanced Search

Announcement & News

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...

SCIENCEDOMAIN Awards

No Awards listed.